Webisodes
Key Industry Drivers: A CEO's Perspective (Part 1)
From health reform's impact on wholesalers to the implementation of electronic medical records, today's key trends (and the pharmaceutical industry's response to them) will have a powerful influence on healthcare delivery. AmerisourceBergen President and CEO Steve Collis joins In the Know to provide his take on these trends-as well as what pharmacies, physicians and manufacturers could learn from one another to improve operations.
(0 Comments)
Date:
January 11, 2012
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest
Steve Collis
President and CEO
AmerisourceBergen
Key Industry Drivers: A CEO's Perspective (Part 2)
In part 2 of this candid conversation, AmerisourceBergen President and CEO Steve Collis highlights growth opportunities for the company in 2012 and beyond, discusses the company's progress toward becoming the industry's easiest company to work with and shares how AmerisourceBergen plans to leverage new technologies for the benefit of its customers.
(0 Comments)
Date:
January 10, 2012
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest
Steve Collis
President and CEO
AmerisourceBergen
Beyond Distribution: The New Role of 3PL
In recent years, the role of third-party logistics (3PL) providers has changed, as have manufacturer considerations when it comes to choosing a partner for 3PL services. Larger issues like the impact of REMS and unpredictable economic conditions raise expectations around the breadth and quality of services demanded by 3PL providers. Tracy Franklin, Senior Director of Client Services for ICS, and Rusty Robertson, Senior Manager for Program Management of ICS, visit "In the Know" to address the changing role of 3PL providers-and how trends like technological advancement continue to influence the market.
(0 Comments)
Date:
December 21, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guests
Tracy Franklin
Senior Director of Client Services
ICS
Rusty Robertson
Senior Manager for Program Management
ICS
Compendia Impact on Coverage and Reimbursement Strategies
The compendia landscape remains dynamic, but often underappreciated - despite the fact that compendia listings influence everything from payer coverage of off-label drug administration to patient access initiatives run by manufacturers. Jacquelyn Hall, Associate Director at Xcenda, stops by "In the Know" to offer insight on the importance of compendia for pharmaceutical manufacturers, as well as best practices for how manufacturers can derive the greatest value from focus in this area.
(0 Comments)
Date:
November 14, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest
Jacquelyn Hall
Associate Director
Xcenda
A Shift In How Manufacturers Approach Patient Assistance
The population of underinsured Americans continues to grow. How can pharmaceutical manufacturers ensure that patients continue to receive appropriate access to medications? Morris Lumpkin, Senior Director of Business Development for Lash Group, joins "In the Know" to discuss how healthcare reform and payer concerns have caused manufacturers to reevaluate their approaches to co-pay and patient assistant programs. He highlights new challenges manufacturers face in this area, as well as best practices that have produced measurable, positive results.
(0 Comments)
Date:
October 18, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Morris Lumpkin
Senior Director of Business Development
Lash Group
Opportunities for Oncology Informatics: Separating Fact from Fiction
When it comes to oncology data and new opportunities, promises abound. But which promises are empty and which ones could create a measurable impact for providers, manufacturers and payers? Mark Johnson, President of ION Solutions, and Jeff Forringer, CEO of IntrinsiQ, join "In the Know" to uncover the clinical and operational value that can be derived from existing data solutions -- and what's realistically on the horizon.
(0 Comments)
Date:
October 5, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guests:
Mark Johnson
President
ION Solutions
Jeff Forringer
President
IntrinsiQ
The Impact of Accountable Care Organizations on Healthcare Delivery
Accountable care organizations might create a paradigm shift for healthcare--but questions remain over implementation costs, provider enthusiasm and performance measurement. Loreen Brown, Vice President of Access and Reimbursement for Xcenda, joins "In the Know" to discuss how providers are responding to the cost and practicality of ACO participation, as well as how ACOs might change the way manufacturers interact with prescribers.
(0 Comments)
Date:
August 8, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Loreen Brown
Vice President of Access and Reimbursement
Xcenda
Health Policy Update: From the SGR Fix to 340B
Is a long-term solution for the SGR fix on the horizon? How will payer awareness of 340B potentially impact drug prices? As ongoing debate in Washington continues to hang over healthcare stakeholders, AmerisourceBergen Consulting Services President Peyton Howell returns to the program to discuss recent issues—from changing deadlines for Meaningful Use requirements, to bridge programs for uninsured Americans and drug shortages.
(0 Comments)
Date:
July 25, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Peyton Howell
President
AmerisourceBergen Consulting Services
Payer Impact on Community Oncology: One Practice's Response
Payers influence on clinical decision-making in oncology continues to grow. Bob Phelan, chief executive officer for Integrated Community Oncology Network in Florida, describes what impact this trend has had on his practice -- and in what ways it could affect patient care nationwide. Bob dives into the evolution of clinical pathways, increased focus on community outreach and how these new dynamics of have forced practice leaders like Bob to re-examine the way they approach daily operations.
(0 Comments)
Date:
May 5, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Bob Phelan
CEO
Integrated Community Oncology Network
Combating Reimbursement Decline through Strategic Planning and Technology
Reimbursement challenges have forced oncology practices to consider new and different ways to increase efficiency without negatively impacting patient care. Bob Phelan, chief executive officer for Integrated Community Oncology Network in Florida, joins "In the Know" to explore how technology and enhanced business processes have offset some of the effect of reduced reimbursement. Bob also addresses gaps in technology's ability to address some ongoing issues, areas where manual processes and oversight continue to be mandatory for optimal results and where technology holds the most promise.
(0 Comments)
Date:
April 26, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Bob Phelan
CEO
Integrated Community Oncology Network
Increasing Effectiveness for Payer Account Management
Manufacturers must prove their products' value to payers to achieve any semblance of success. But do manufacturers understand payer thought processes well enough to create the most compelling value propositions for their products? Tom Mullin, vice president of customer relations for Xcenda, discusses how successful manufacturers have taken a more comprehensive look at what drives payer decisions - from how payers assess clinical results to how they manage financial risk. Tom describes how manufacturers can then use that information to refine their products' differentiating points in ways that matter to payer decision-makers.
(0 Comments)
Date:
April 19, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Tom Mullin
Vice President of Customer Relations
Xcenda
The impact of reimbursement changes on community oncology (Part 2)
In the conclusion of this two-part webisode, onPoint Oncology Principal Bobbi Buell rejoins the program to continue her discussion about reimbursement challenges and the opportunities facing community oncology practices. Ms. Buell focuses on the financial implications, EMR adoption, stumbling blocks of e-prescribing and the requirements practices must meet to qualify for short-term incentives.
(0 Comments)
Date:
April 4, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Bobbi Buell
onPoint Oncology
The impact of reimbursement changes on community oncology (Part 1)
"In The Know" welcomes onPoint Oncology Principal Bobbi Buell as she and host Gina Clark discuss how community oncology practices are responding to the host of changes throughout the reimbursement landscape. In the first section of this two-part webisode, Ms. Buell provides best practices and sage guidance for practices—addressing ongoing concerns over the SGR fix, the Medicare Physician Fee Schedule, as well as other coding changes that impact community oncology practices.
(0 Comments)
Date:
March 28, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Bobbi Buell
onPoint Oncology
RFID Technology's Increasing Importance in Specialty Distribution
Data collection, track and trace, and other new distribution capabilities could have a significant impact on the type of product information available to manufacturers and physicians. At the same time, new distribution mechanisms can vastly reduce the time it takes for healthcare organizations and patients to access life-saving medications. Chris Flori (VP of Business Management Solutions for ASD Healthcare) discusses the role of the pharmaceutical consignment market in the supply chain and how technologies like RFID are having an impact on all aspects of the product lifecycle when it comes to specialty pharma.
(0 Comments)
Date:
March 11, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guest:
Chris Flori
Vice President of Business Management Solutions
ASD Healthcare
Beyond Clinical Pathways: Reducing Variability of Care (Part 2)
The relationship between private payers and community oncology practices continues to evolve amid ongoing debate over cost versus quality in cancer care. Practices work to deliver the best possible care for their patients—all the while keeping an eye toward new therapeutic management strategies, like clinical pathways. Mark Johnson (President, ION Solutions) and Becky Knockemus (Senior Director of Practice Solutions, ION Solutions) are on hand for the conclusion of our two-part webisode regarding the processes involved with implementing medical home and other comprehensive strategies, as well as obstacles that may stand in the way.
(0 Comments)
Date:
February 21, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guests:
Mark Johnson
President
ION Solutions
Becky Knockemus
Senior Director of Practice Solutions
ION Solutions
Beyond Clinical Pathways: Reducing Variability of Care (Part 1)
The relationship between private payers and community oncology practices continues to evolve amid ongoing debate over cost versus quality in cancer care. Practices work to deliver the best possible care for their patients—all the while keeping an eye toward new therapeutic management strategies, like clinical pathways. Mark Johnson (President, ION Solutions) and Becky Knockemus (Senior Director of Practice Solutions, ION Solutions) are on hand for part one of our two-part webisode regarding the processes involved with implementing medical home and other comprehensive strategies, as well as obstacles that may stand in the way.
(0 Comments)
Date:
February 7, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guests:
Mark Johnson
President
ION Solutions
Becky Knockemus
Senior Director of Practice Solutions
ION Solutions
Greater Product Insight through Informatics
New solutions for clinical and supply chain informatics play an ever-growing role in providing operational data and clinical insight that impact manufacturer, payer and provider strategies. AmerisourceBergen Specialty Group’s Matt Johnson (Vice President of Strategy) and Cory Shouse (Director of Enterprise Business Intelligence) return to “In The Know” to discuss which therapeutic areas look to provide the greatest ROI, what information can be derived from current solutions and how physician attitudes toward data sharing might influence the future of informatics.
(0 Comments)
Date:
January 31, 2011
Host:
Gina Clark
Chief Marketing Officer
AmerisourceBergen
Guests:
Matt Johnson
Vice President of Strategy
AmerisourceBergen Specialty Group
Cory Shouse
Director of Enterprise Business Intelligence
AmerisourceBergen Specialty Group
Optimizing Resources for Oncology Practices
Season 2 of "In the Know" kicks off with a look at how some of the nation's largest and most influential oncology practices are using new technologies and streamlining operations to address challenges such as reduced reimbursement and increased competition. Matt Webb, Vice President for ION Solutions, outlines how practices can respond to growth inhibitors, implement strategic planning processes to increase efficiencies and leverage new opportunities in payer relations.
(0 Comments)
Date:
January 18, 2011
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Matt Webb
Vice President
ION Solutions
Marketing Matters: How Community Oncology Practices Can Expand Market Outreach in Economically Challenging Times
Community oncology practices today face more dire economic circumstances than at any other time in recent memory. Practices have responded by taking significant measures to increase efficiencies related to everything from personnel to pharmaceutical purchasing. But could they derive similar benefits from devoting more resources toward strategic marketing initiatives? Jim O'Gara, Founder and President of OnMessage, joins "In the Know" to provide his expertise on how oncology practices can intelligently invest in expanding their approach to market outreach--moving well beyond traditional referral channels to create a strong brand in their communities (without breaking the bank).
(0 Comments)
Date:
November 8, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Jim O'Gara
Founder and President
OnMessage
Beyond Pick, Pack and Ship: Expanded Value of Distributors for Manufacturer Brand Teams and Sales Organizations
As manufacturers continue to reduce their workforces, gaps around market outreach and supply chain analytics become more apparent. How can pharmaceutical companies rethink the way they interact with distribution companies to create novel solutions that fill these gaps? Chris Myers, Chief Operating Officer for ASD Healthcare, and George Rafferty, Vice President of Sales for ASD Healthcare, join "In the Know" to offer their thoughts on how some distribution companies have taken term "trade partner" to heart--providing services that complement manufacturers' sales teams and other staff to drive product awareness, adoption and accurate analysis.
(0 Comments)
Date:
October 18, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guests:
Chris Myers
Chief Operating Officer
ASD Healthcare
George Rafferty
Vice President of Sales
ASD Healthcare
Risk and Reward: Navigating REMS pitfalls to position brands for success
Risk evaluation and mitigation strategies (REMS) hold the potential to cause anxiety around everything from prescribing processes and patient adherence to payer relations and patient access. At the same time, REMS could translate to strategic opportunities for companies that handle them correctly. Terri Madison, vice president of epidemiology and risk management for Xcenda, joins the program to detail how changes in REMS will require changes in how manufacturers approach their specialty product strategy.
(0 Comments)
Date:
August 31, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guests:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
Terri Madison
Vice President, Epidemiology and Risk Management
Xcenda
Expanded Impact of Specialty Pharmacies on Pharma, Providers, Patients and Payers
Collaboration between specialty pharmacies, healthcare providers, payers and patients has grown substantially in recent years--but what further enhancements can be made? Craig Miller, Vice President of Business Development for US Bioservices, joins us to provide his thoughts on the expanding role that specialty pharmacies play in the care delivery process. He discusses how new technologies and services in the pharmacy industry can create efficiencies and value even outside the pharmacy environment. Specifically, he addresses how tools like prescriber portals and high touch reimbursement and adherence programs can reduce administrative burden for physicians, improve product adherence rates for pharma and reduce variability of care of payers.
(0 Comments)
Date:
August 6, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Craig Miller
Vice President of Business Development
US Bioservices
Policy and Providers: New Legislation's Effect on Physician Practices
Health policy expert Peyton Howell rejoins "In the Know" to detail how recent legislation will impact specialty care providers. View our discussion on what immediate advantages might come from recent policy changes, and what longer terms efforts might arise from expanding health benefits to so many more Americans. Ms. Howell also dives into key provider issues like the latest in REMS requirements, the government's role in technology adoption within practices and 340B in the oncology market.
(0 Comments)
Date:
July 16, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
Health Policy Changes: What Continues to Keep Pharma Up at Night?
With the finer details of health reform now taking shape, health policy expert Peyton Howell joins "In the Know" to discuss the impact on pharmaceutical and biotech manufacturers. Ms. Howell offers insight into how the mid-term elections might play into the pharma community's strategic decision-making, as well as why changes to issues like 340B pricing and Medicare physician reimbursement hold significant potential to disrupt "business as usual" in the delivery of healthcare.
(0 Comments)
Date:
July 6, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
Clinical Pathways and Other Cost-efficiency Initiatives Impacting Cancer Care (Part 2)
In the second of our two-part webisode, Oncology Physician Resource's Lesli Lord rejoins us to tell what steps oncology practices are taking to implement clinical pathways and ensure compliance. She brings up the practical balance between the cost and quality of care, as it relates to pathway development. And she discusses how practice technologies-like electronic medical records-combine with proper workflow to aggregate and output the data required by the payer community.
(0 Comments)
Date:
June 2, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Lesli Lord
Executive Director
Oncology Physician Resource
Clinical Pathways and Other Cost-efficiency Initiatives Impacting Cancer Care (Part 1)
Explore how the economics of cancer care have changed and what practices are doing to maintain financial viability, without reducing the quality of patient care. Lesli Lord, executive director for Oncology Physician Resource, joins us for part one of our two-part webisode to discuss how initiatives like clinical pathways can create win-win situations for oncology practices, payers--as well as manufacturers. She also dives into the impact that generic alternatives might have on a practice's ability to drive cost efficiencies.
(0 Comments)
Date:
May 18, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Lesli Lord
Executive Director
Oncology Physician Resource
Provider-facing Technologies' Impact on Pharma's Success
Traditionally, healthcare has been viewed as lagging behind other industries when it comes to technology innovation and adoption. But with technologies like electronic medical records and e-prescribing growing in popularity, this image may be changing-and with that change comes new opportunities for providers, patients, payers and pharma. Dale Danilewitz, chief information officer for AmerisourceBergen Specialty Group, and Neil Herson, president for ASD Healthcare, join "In the Know" to discuss how broader adoption of provider-facing technologies can help facilitate improved data aggregation, clinical analysis and product planning. They also dive into the effect that general consumer electronic trends have had in patient expectations and provider behavior.
(0 Comments)
Date:
May 3, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guests:
Dale Danilewitz
Chief Information Officer
AmerisourceBergen
Specialty Group
Neil Herson
President
ASD Healthcare
Commercialization Best Practices for Small and Mid-sized Pharma
Issues like health policy changes and industry consolidation have impacted the entire pharmaceutical market, but small and mid-sized pharmaceutical companies have responded to these issues in a different-and often more nimble-way. Doug Cook, vice president of operations for ICS, joins In the Know to explore the unique mindset that many smaller pharmaceutical companies have as they approach commercialization decisions around logistics, regulatory compliance and data requirements. He also discusses what larger manufacturers might learn from small pharma's best practices.
(0 Comments)
Date:
April 19, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Doug Cook
Vice President, Operations
ICS
Patient Assistance Programs in the New Decade: Analysis and Best Practices for Pharmaceutical Manufacturers
Find out how pharmaceutical manufacturers may be adjusting their approach to patient assistance and co-pay assistance programs in response to the global economic recession, the increase of uninsured and underinsured populations, as well as potential changes in U.S. health policy. Nancy McGee, chief operating officer for Lash Group, joins In the Know to discuss how patient assistance programs have changed in recent years--as well as what manufacturers can continue to do to ensure appropriate access to their products in the years to come.
(0 Comments)
Date:
March 17, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Nancy McGee
Chief Operating Officer
Lash Group
Health Reform and Pharma: What Happens Next?
Noted healthcare policy expert Peyton Howell rejoins In the Know for an update on the viability of healthcare reform. She discusses how recent changes will impact manufacturers, patients and providers-as well as what manufacturers can be doing now in the wake of continued uncertainty.
(0 Comments)
Date:
March 3, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
One-on-one with Oncology Business Review: Examining the Present and Future of Cancer Care
"Oncology Business Review" Founder and Publisher Don Sharpe joins "In the Know" for a candid discussion where the interviewer becomes the interviewee. Don offers his thoughts on the positive trends in the oncology market that many people seem to have forgotten, as well as the negatives that can't be ignored. He weighs in on the cost v. quality debate in cancer care and provides recommendations on what manufacturers can do to increase the real and perceived value of their products.
(0 Comments)
Date:
February 22, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Don Sharpe
Founder and Publisher
Oncology Business Review
Supply Chain v. Value Chain: Evaluating the Role that Distributors and Specialty Pharmacies Play in Product Success
Learn how relationships between distributors, specialty pharmacies and manufacturers are changing--motivated in part by manufacturers' need for more detailed reporting data and more robust clinical services. Neil Herson, President of ASD Healthcare, and Mark Johnson, President of US Bioservices, discuss how manufacturer expectations of distributors and specialty pharmacies have changed over the years and what organizations like theirs are doing to drive specialty product growth.
(0 Comments)
Date:
February 12, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guests:
Neil Herson
President
ASD Healthcare
Mark Johnson
President
US Bioservices
Managed Care's Mindset: How Payers and PBMs Are Approaching the Specialty Space
Explore how managed care companies are working to provide appropriate access to specialty pharmaceuticals--while also working to ensure overall cost-efficiency. Gary Rice, director of specialty clinical management at MedImpact, discusses how the managed care industry is approaching the "cost vs. value" debate, increased interaction between payers, pharma and providers, as well as hot-button issues like biosimilars and comparative effectiveness.
(0 Comments)
Date:
January 22, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Gary Rice
Director of Specialty Clinical Management
MedImpact
Clarity on Comparative Effectiveness: How and When Will It Be Used by Payers
Gain insight on how comparative effectiveness may be rolled out in the United States, how it will differ from models in Europe and Canada and what other utilization management initiatives may be on the horizon. Bob Mauch, president of Xcenda, discusses this and what pharma can do to ensure continued product success and patient access to medications.
(0 Comments)
Date:
January 6, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Bob Mauch
President
Xcenda
Managing Managed Care: Changing Relationships between Payers, Pharma and Providers
Learn how payers have forced a change in pharma's approach to launching and commercializing their products. Bob Mauch, president of Xcenda, discusses how pharma companies can address changes in product value messaging, interactions among pharma and payers, as well as potential game-changers like comparative effectiveness to drive product success.
(0 Comments)
Date:
December 14, 2009
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Bob Mauch
President
Xcenda
Oncology Outlook: Real-world Insight from Inside a Practice
Learn how community oncology is responding to declining reimbursement, health policy changes and changing expectations from managed care. Alana Vaughn, practice administrator for Louisiana Hematology Oncology Associates, and Bobby Pope, vice president of sales for ION, also discuss the impact that new practice efficiency tools and new oral oncology products are having on the delivery of cancer care.
(0 Comments)
Date:
December 4, 2009
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guests:
Alana Vaughn
Practice Administrator
Louisiana Hematology Oncology Associates
Bobby Pope
Vice President, Sales
ION
Top Five Health Reform Issues that Pharma Needs to Monitor
Learn the five key health reform issues that are poised to impact pharmaceutical manufacturers-as well as the challenges and opportunities these issues represent.
(0 Comments)
Date:
October 29, 2009
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
Using Informatics for More Informed Product Decisions
A closer look at the impact that accurate and timely product data can have on a product's success.
(0 Comments)
Date:
October 9, 2009
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guests:
Matt Johnson
Vice President, Strategy
AmerisourceBergen
Specialty Group
Cory Shouse
Director, Enterprise Business Intelligence
AmerisourceBergen
Specialty Group